Sapphire Bioscience Holding ApS Financials, key figures and credit report
Gross profit - 112.0 kDKK FY 2025 +36% vs 2024
EBIT - 112.0 kDKK FY 2025 +36% vs 2024
Net debt 29 597.0 kDKK FY 2025 +160% vs 2024
Quick ratio 0.3 FY 2025 +0 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -12.00 | -64.00 | -49.00 | - 175.00 | - 112.00 |
| EBIT | -12.00 | -64.00 | -49.00 | - 175.00 | - 112.00 |
| Other financial income | 36 129.00 | 44 424.00 | 28 379.00 | 8.00 | 53.00 |
| Other financial expenses | - 291.00 | - 628.00 | - 266.00 | - 337.00 | -1 313.00 |
| Net income from associates (fin.) | 39 127.00 | 4 354.00 | |||
| Pre-tax profit | 35 826.00 | 43 732.00 | 28 064.00 | 38 623.00 | 2 982.00 |
| Income taxes | -1.00 | 10.00 | -42.00 | 170.00 | 284.00 |
| Net earnings | 35 825.00 | 43 742.00 | 28 022.00 | 38 793.00 | 3 266.00 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 143 847.00 | 188 146.00 | 156 953.00 | 191 970.00 | 178 418.00 |
| Investments total | 143 847.00 | 188 146.00 | 156 953.00 | 191 970.00 | 178 418.00 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 8 537.00 | 24 230.00 | 10 764.00 | ||
| Prepayments and accrued income | 4.00 | 5.00 | 4.00 | 5.00 | 5.00 |
| Current other receivables | 672.00 | 3.00 | 71.00 | ||
| Current deferred tax assets | 2 857.00 | 9 631.00 | 3 493.00 | 3 018.00 | 284.00 |
| Short term receivables total | 11 398.00 | 34 538.00 | 3 500.00 | 3 094.00 | 11 053.00 |
| Cash and bank deposits | 193.00 | 1 233.00 | 269.00 | 591.00 | 1 620.00 |
| Cash and cash equivalents | 193.00 | 1 233.00 | 269.00 | 591.00 | 1 620.00 |
| Balance sheet total (assets) | 155 438.00 | 223 917.00 | 160 722.00 | 195 655.00 | 191 091.00 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 15 878.00 | 15 878.00 | 15 878.00 | 15 878.00 | 15 878.00 |
| Shares repurchased | 31 755.00 | ||||
| Other reserves | 96 744.00 | 141 476.00 | 111 410.00 | 125 514.00 | 111 961.00 |
| Retained earnings | -4 116.00 | -43 894.00 | - 998.00 | 530.00 | 17 172.00 |
| Profit of the financial year | 35 825.00 | 43 742.00 | 28 022.00 | 38 793.00 | 3 266.00 |
| Shareholders equity total | 144 331.00 | 188 957.00 | 154 312.00 | 180 715.00 | 148 277.00 |
| Non-current liabilities total | |||||
| Current trade creditors | 31.00 | 40.00 | 25.00 | 57.00 | 71.00 |
| Current owed to group member | 8 350.00 | 24 759.00 | 4 500.00 | 11 976.00 | 31 217.00 |
| Short-term deferred tax liabilities | 2 716.00 | 4 650.00 | 1 875.00 | 2 907.00 | |
| Other non-interest bearing current liabilities | 10.00 | 5 511.00 | 10.00 | 11 526.00 | |
| Current liabilities total | 11 107.00 | 34 960.00 | 6 410.00 | 14 940.00 | 42 814.00 |
| Balance sheet total (liabilities) | 155 438.00 | 223 917.00 | 160 722.00 | 195 655.00 | 191 091.00 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 The current price above includes VAT and is paid securely through Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated